Literature DB >> 1438251

Identification of a negative regulatory function for steroid receptors.

D P McDonnell1, E Vegeto, B W O'Malley.   

Abstract

This report describes the identification of a negative regulator of estrogen and progesterone receptor function. Using a reconstituted estrogen-responsive transcription system in Saccharomyces cerevisiae, we have identified a "repressor function," which when mutated, increases the transcriptional activity of the estrogen and progesterone receptors. In the case of the estrogen receptor this mutation increases the sensitivity of estrogen-mediated activation by at least four orders of magnitude. Analysis of derivatives of the estrogen receptor indicated that this repressor specifically affects the transcription activity of the TAF1 activation domain of the estrogen receptor. The repressor was cloned by complementation and identified as SSN6, a previously described mediator of glucose repression in yeast. Our results indicate that SSN6 is likely to be involved also in the repression of other cellular activators. Interestingly, deletion of the SSN6 protein allows the antiestrogens ICI 164384 and nafoxidine to behave as more potent agonists of estrogen receptor function, while RU486 also becomes a more potent activator of progesterone receptor function. These data suggest that in wild-type cells the role of hormone is twofold: it promotes DNA binding of the receptor and it also induces a conformational change in the receptor which overcomes the effects of this repressor function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438251      PMCID: PMC50381          DOI: 10.1073/pnas.89.22.10563

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor.

Authors:  J A Lees; S E Fawell; M G Parker
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

2.  Interaction of the chicken progesterone receptor with heat shock protein (HSP) 90.

Authors:  M A Carson-Jurica; A T Lee; A W Dobson; O M Conneely; W T Schrader; B W O'Malley
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

3.  Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.

Authors:  S E Fawell; R White; S Hoare; M Sydenham; M Page; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Identification of two transactivation domains in the mouse oestrogen receptor.

Authors:  J A Lees; S E Fawell; M G Parker
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

5.  The N-terminal TPR region is the functional domain of SSN6, a nuclear phosphoprotein of Saccharomyces cerevisiae.

Authors:  J Schultz; L Marshall-Carlson; M Carlson
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  GAL11P: a yeast mutation that potentiates the effect of weak GAL4-derived activators.

Authors:  H J Himmelfarb; J Pearlberg; D H Last; M Ptashne
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  The human estrogen receptor has two independent nonacidic transcriptional activation functions.

Authors:  L Tora; J White; C Brou; D Tasset; N Webster; E Scheer; P Chambon
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

8.  Superactive estrogen receptors. Potent activators of gene expression.

Authors:  J F Elliston; S Y Tsai; B W O'Malley; M J Tsai
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

9.  Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression.

Authors:  D P McDonnell; R A Scott; S A Kerner; B W O'Malley; J W Pike
Journal:  Mol Endocrinol       Date:  1989-04

10.  Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae.

Authors:  D P McDonnell; J W Pike; D J Drutz; T R Butt; B W O'Malley
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

View more
  22 in total

Review 1.  Minireview: nuclear receptor and coregulator proteomics--2012 and beyond.

Authors:  Bert W O'Malley; Anna Malovannaya; Jun Qin
Journal:  Mol Endocrinol       Date:  2012-06-28

Review 2.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Cucurbitacins are insect steroid hormone antagonists acting at the ecdysteroid receptor.

Authors:  L Dinan; P Whiting; J P Girault; R Lafont; T S Dhadialla; D E Cress; B Mugat; C Antoniewski; J A Lepesant
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors.

Authors:  E vom Baur; M Harbers; S J Um; A Benecke; P Chambon; R Losson
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 5.  Steroid receptor coactivators: servants and masters for control of systems metabolism.

Authors:  Erin Stashi; Brian York; Bert W O'Malley
Journal:  Trends Endocrinol Metab       Date:  2014-06-19       Impact factor: 12.015

Review 6.  Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology.

Authors:  Subhamoy Dasgupta; Bert W O'Malley
Journal:  J Mol Endocrinol       Date:  2014-07-14       Impact factor: 5.098

7.  Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

Authors:  Gloria S Huang; Alessandro D Santin
Journal:  Cancer       Date:  2017-05-09       Impact factor: 6.860

8.  Interaction of proteins with transcriptionally active estrogen receptors.

Authors:  V Cavaillès; S Dauvois; P S Danielian; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 9.  The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis.

Authors:  Erik R Nelson; Suzanne E Wardell; Donald P McDonnell
Journal:  Bone       Date:  2012-11-17       Impact factor: 4.398

10.  From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).

Authors:  Suzanne E Wardell; Erik R Nelson; Donald P McDonnell
Journal:  Steroids       Date:  2014-07-30       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.